Prednisone for adults with autism and immune issues
Treatments studied
Part of Brain & nervous system, Immune system & allergy, Mental health clinical trials.
This trial tests if the steroid prednisone can help adults with moderate-to-severe autism who also have signs of immune system problems, like autoimmune disease or inflammation. It might offer a new treatment option for people whose autism is linked to immune activity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are male, 18–50 years old.
- You have a diagnosis of autism spectrum disorder (ASD) that requires substantial support (level 2 or 3).
- Your symptoms are at least moderate in severity.
- You have either an autoimmune disease, high inflammation markers in blood, or a strong family history of autoimmune disease.
- You have a study partner (like a caregiver) who speaks English and can attend visits with you.
- You can swallow large capsules and keep your current treatments stable for 4 weeks before starting.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental medication called TB006 for adults with autism. It aims to see if it can help reduce symptoms. Participants must be 18–35, have moderate-to-severe autism, and have a caregiver who can join them.
This study tests whether an antioxidant supplement (something that fights cell damage) can help children with autism. It lasts 3 months and requires that the child stays on their current treatments without changes.
This study observes how intranasal insulin (a form of insulin delivered through the nose) affects children and young adults with autism spectrum disorder who are already using or planning to use it as part of their regular care. Researchers will track changes in behavior and social skills over about 6 months.
This Phase 2 study tests whether diphenhydramine improves sleep in children with autism who have significant sleep problems. It requires sleep monitoring (watch data and sleep testing) and checking for side effects to see if the treatment is safe and helpful.
This trial tests whether buspirone, a medication that helps with anxiety, can reduce anxiety in children and teens with autism. It is a 12-week study where participants receive buspirone or a placebo (a pill with no medicine) to see if it improves anxiety symptoms.
This study tests whether a daily probiotic supplement (a mix of good bacteria) can help reduce autism symptoms in children. It lasts 3 months and involves filling out questionnaires about your child's behavior at the start and end of the trial.
Hear when a new Autism spectrum disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.